Lung Disease News and Research

RSS

High-dose flu vaccine protects older adults with lung disease

The risk of being hospitalized for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

8 Sep 2026

New biologic therapy significantly reduces COPD flare-ups in trials

Two international clinical trials led in part by researchers at the University of Pittsburgh School of Medicine found that the investigational biologic therapy tozorakimab significantly reduced chronic obstructive pulmonary disease (COPD) flare-ups among patients already receiving standard treatment for the disease compared to patients only receiving standard treatment.

8 Sep 2026

AI-designed drug candidate reverses biological age in clinical study

Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, today announced the publication of a new study conducted in collaboration with an international team of scientists from Harvard Medical School, Stanford University, The Broad Institute, RWTH Aachen University, Peking University and Westlake University.

7 Sep 2026

Laughter therapy eases breathlessness in people with COPD

A clinical trial for patients with chronic obstructive pulmonary disease (COPD) shows that laughter therapy can reduce breathing difficulties and is as effective as more traditional breathing exercises. The research is presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

6 Sep 2026

Bacteria found in classroom dust may affect children’s respiratory health

Common bacteria found in classroom dust are associated with reduced lung function in children according to research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

6 Sep 2026

Genetic COPD risk emerges early with higher air pollution

Chronic obstructive pulmonary disease (COPD) is a serious, incurable lung disease that is common in older people.

6 Sep 2026

Researchers find greater microplastic burden in lung cancer patients

People with lung cancer are more likely to have microplastics in their lungs and to have larger quantities of microplastics in their lungs, according to research that will be presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

4 Sep 2026

Blocking a naturally occurring molecule reverses deadly lung disease in preclinical models

Researchers blocked a naturally occurring molecule to reverse pulmonary arterial hypertension in preclinical models, a finding that could point to a new treatment approach for people with a rare and often fatal lung disease.

2 Sep 2026

Women with shorter reproductive lifespan face higher risk of developing bronchiectasis

Women with a shorter reproductive lifespan are at greater risk of developing bronchiectasis, according to a new study in the July 2026 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open access journal.

27 Aug 2026

New artificial lung mimics breathing and alveolar movement

Almost everyone has blown a soap bubble through a straw at least once. Inspired by this thin soap bubble film, an "artificial lung that breathes" like a real lung has been developed.

25 Aug 2026

California landscapes linked to differing rates of Valley fever

Researchers from University of California San Diego and University of California, Berkeley have found that certain landscapes surrounding California communities are associated with differing rates of Valley fever, a fungal respiratory infection caused by inhaling spores carried in windblown dust.

24 Aug 2026

Opening the black box of biological aging clocks

What do "epigenetic clocks" actually measure? These lab tests have become popular tools for studying biological aging, or how the body's cellular function changes at a faster or slower rate than expected.

14 Aug 2026

Dexamethasone calms lung inflammation without weakening core immune responses

Researchers from Trinity College Dublin and St. James's Hospital have shown that dexamethasone, a commonly prescribed anti-inflammatory steroid, can reduce harmful inflammation triggered by Mycobacterium avium without weakening the ability of human immune cells to control the infection.

11 Aug 2026

Engineered extracellular vesicles counter deadly cytokine storms in mice

The COVID-19 pandemic highlighted some severe consequences of unchecked respiratory disease, including cytokine storm.

31 Jul 2026

Cigarette smoke extract primes airway cells for greater nanoplastic damage

Researchers found that cigarette smoke extract weakened epithelial barriers and increased the proportion of human airway cells that were polystyrene nanoparticle-positive. Sequential treatment caused greater metabolic disruption and increased mucus-producing cells, suggesting heightened epithelial vulnerability, although the findings are limited to in vitro models.

30 Jul 2026